Legal status · United States
Is Verteporfin legal in the United States?
Yes. Verteporfin is an approved medicine in the United States, classified as "Prescription only (approved for eye use); wound use off-label/investigational". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Verteporfin in the United States at a glance
| Classification | Prescription only (approved for eye use); wound use off-label/investigational |
|---|---|
| FDA approval status | FDA-approved for ocular photodynamic therapy; wound use is investigational (Phase 2) |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Verteporfin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Verteporfin for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Verteporfin is
An approved eye drug that, injected into wounds in mice, produced regeneration without scars in a landmark 2021 Science paper; the first human scar trial started in June 2026, and off-label self-use carries days of severe photosensitivity.
Verteporfin is FDA-approved for photodynamic therapy in macular degeneration. Stanford researchers showed that blocking YAP with verteporfin stops Engrailed-1 activation in wound fibroblasts, so mouse wounds heal with hair follicles and glands instead of scar tissue.
Mechanism: Inhibits YAP-TEAD signaling, preventing Engrailed-1 lineage activation in fibroblasts and shifting healing toward regeneration.
Regulatory history: FDA-approved for ocular photodynamic therapy; wound use is investigational (Phase 2)
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Verteporfin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Verteporfin in other countries
Frequently asked questions
Is Verteporfin legal in the United States?
Yes. Verteporfin is an approved medicine in the United States, classified as "Prescription only (approved for eye use); wound use off-label/investigational". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Preliminary.
Can I buy Verteporfin in the United States?
Only with a prescription. Verteporfin is classified as "Prescription only (approved for eye use); wound use off-label/investigational" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Verteporfin FDA approved?
Yes. FDA status: FDA-approved for ocular photodynamic therapy; wound use is investigational (Phase 2). Current US classification: "Prescription only (approved for eye use); wound use off-label/investigational". Evidence level: Preliminary.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Verteporfin live on its compound profile.
Verteporfin profileThis page is general information about the regulatory status of Verteporfin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.